Brown Brothers Harriman & Co’s Kyntra Bio KYNB Stock Holding History

Brown Brothers Harriman & Co’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-97	Closed	-$2.1K	–	1192
2023 Q3	$2.1K	Hold	97	–	–	﹤0.01%	1098
2023 Q2	$6.58K	Hold	97	–	–	﹤0.01%	1022
2023 Q1	$45.4K	Hold	97	–	–	﹤0.01%	749
2022 Q4	$39K	Hold	97	–	–	﹤0.01%	763
2022 Q3	$32K	Hold	97	–	–	﹤0.01%	850
2022 Q2	$26K	Sell	97 -86	-47%	-$22K	﹤0.01%	826
2022 Q1	$55K	Hold	183	–	–	﹤0.01%	745
2021 Q4	$65	Hold	183	–	–	﹤0.01%	659
2021 Q3	$47	Hold	183	–	–	﹤0.01%	691
2021 Q2	$122	Hold	183	–	–	﹤0.01%	522
2021 Q1	$159	Hold	183	–	–	﹤0.01%	459
2020 Q4	$170K	Hold	183	–	–	﹤0.01%	467
2020 Q3	$189K	Hold	183	–	–	﹤0.01%	394
2020 Q2	$186K	Hold	183	–	–	﹤0.01%	386
2020 Q1	$159K	Hold	183	–	–	﹤0.01%	381
2019 Q4	$197K	Hold	183	–	–	﹤0.01%	469
2019 Q3	$170K	Hold	183	–	–	﹤0.01%	451
2019 Q2	$207K	Hold	183	–	–	﹤0.01%	388
2019 Q1	$249K	Hold	183	–	–	﹤0.01%	349
2018 Q4	$212K	Hold	183	–	–	﹤0.01%	336
2018 Q3	$279K	Hold	183	–	–	﹤0.01%	311
2018 Q2	$287K	Hold	183	–	–	﹤0.01%	294
2018 Q1	$212K	Hold	183	–	–	﹤0.01%	318
2017 Q4	$217K	Hold	183	–	–	﹤0.01%	333
2017 Q3	$247K	Buy	+183	New	+$193K	﹤0.01%	302

Other funds holding KYNB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Brown Brothers Harriman & Co's KYNB Position: Q4 2023 in Review

Brown Brothers Harriman & Co sold out of Kyntra Bio (KYNB) in Q4 2023, closing a stake of 97 shares — an estimated $2.1K sold.

Brown Brothers Harriman & Co first reported a position in KYNB in Q3 2017 and held it in 25 quarters. The position peaked at $287K in Q2 2018. 100 funds tracked by Wall St. Rank hold KYNB as of Q4 2023.

Brown Brothers Harriman & Co reported no remaining Kyntra Bio position as of Q4 2023 after selling out during the quarter.
Brown Brothers Harriman & Co sold 97 Kyntra Bio shares in Q4 2023, an estimated $2.1K.
Brown Brothers Harriman & Co first reported a position in Kyntra Bio in Q3 2017 and held it in 25 quarters.
Brown Brothers Harriman & Co's Kyntra Bio position peaked at $287K in Q2 2018.
100 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2023.

Based on Brown Brothers Harriman & Co's 13F filing for Q4 2023, filed 12 Feb 2024.